In 2020, the epidemic of COVID-19 has spread in the whole world, and COVID-19 diagnostic kit is definitely a purchasing point from the beginning. Hukui Bio has been authorized bytwo Taiwan nucleic acid diagnostic kit factories to begin providing COVID-19 diagnostic kit for Europe, ASEAN and South America markets, hoping to satisfy their local medical resources.
HukuiBio CEO, Michael Kuo said, “Because of the U.S.-China trade war and epidemic COVID-19, the global medical device demand and supply will be overwhelmed changed.” After obtaining investment from European private equity fund- YELLOWSTONE at the end of last year, HukuiBio expands the business to worldwide medical device design, registration and manufacturing service. HukuiBio integrates its network with design/production/regulation ability in China and Taiwan market to provide worldwide medical device registration, including TFDA, NMPA, ISO 13485, GMP consultant, and OEM/ODM service, even Asian market development.
Today, the epidemic of COVID-19 is spreading around the world. Many areas are searching support from medical advanced countries such as Taiwan. HukuiBio is selling COVID-19 diagnostic kit to ASEAN countries through its network. Meanwhile, HukuiBio is looking for more products to provide the best support in order to accomplish the serious epidemic prevention task.
